NRF3 mRNA levels in whole skin/tumor samples did not differ between AK, BCC, and normal human skin, while an increase was seen in 3 out of 9 SCCs (Fig 1A). This evidence concerns the gene NFE2L3 and skin basal cell carcinoma.